In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...
The latest data identifies biohealth as a bright spot in VC funding for female founders, most significantly in the Northeast.
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
Psy Therapeutics, based in Boston, MA, focused on discovering and developing treatments for neuropsychiatric and neurodegenerative disorders, today announced that David Barlow, Chair & CEO, and Alan ...
Bicara Therapeutics Inc.’s BCAX share price has dipped by 10.28%, which has investors questioning if this is right time to ...
The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...
Astria Therapeutics, Inc.’s ATXS share price has surged by 11.17%, which has investors questioning if this is right time to ...
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results